← Open Payments lookup

RUTH MOLLET: Open Payments

NPI 1992246516 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,996 in 84 payments from 15 companies in 2025. Trend: 2023 $1,275 · 2024 $1,963 · 2025 $1,996

Food & beverage: $1,996
CompanyPaymentsAmount
ABBVIE INC.30$534
Lilly USA, LLC7$385
Janssen Biotech, Inc.12$205
Madrigal Pharmaceuticals3$160
Takeda Pharmaceuticals U.S.A., Inc.5$133
GENZYME CORPORATION4$105
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$97
Aimmune Therapeutics, Inc.4$94
Regeneron Healthcare Solutions, Inc.3$73
Ardelyx, Inc.4$68

Products named: RINVOQ, OMVOH, TREMFYA, DUPIXENT, REZDIFFRA, XIFAXAN, ZENPEP, MAVYRET.

Industry payments across WA — which companies pay providers there.